[BSTEAD] QoQ TTM Result on 30-Sep-2010 [#3]

Stock
[BSTEAD] BOUSTEAD HOLDINGS BHD
Announcement Date
29-Nov-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Sep-2010 [#3]
Profit Trend
QoQ- 1.21%
YoY- 56.43%
Quarter Report
Latest QR
Upcoming QR
BSTEAD's Result
BSTEAD's Financial Summary
View:
Show?
TTM Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 7,016,500 6,216,200 6,181,800 5,973,100 5,878,300 5,729,500 5,392,000 19.24%
PBT 824,500 759,800 726,200 682,200 654,000 550,100 501,600 39.40%
Tax -107,700 -104,600 -101,300 -112,700 -100,600 -95,300 -83,200 18.83%
NP 716,800 655,200 624,900 569,500 553,400 454,800 418,400 43.31%
-
NP to SH 598,200 559,500 537,500 476,300 470,600 371,000 341,600 45.43%
-
Tax Rate 13.06% 13.77% 13.95% 16.52% 15.38% 17.32% 16.59% -
Total Cost 6,299,700 5,561,000 5,556,900 5,403,600 5,324,900 5,274,700 4,973,600 17.11%
-
Net Worth 4,343,268 4,222,782 4,230,648 4,091,760 4,054,910 3,950,297 3,829,207 8.78%
Dividend
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Div 300,932 394,363 365,380 343,735 282,931 222,053 208,354 27.86%
Div Payout % 50.31% 70.48% 67.98% 72.17% 60.12% 59.85% 60.99% -
Equity
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Net Worth 4,343,268 4,222,782 4,230,648 4,091,760 4,054,910 3,950,297 3,829,207 8.78%
NOSH 940,101 940,486 940,144 940,634 934,311 925,128 911,716 2.07%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin 10.22% 10.54% 10.11% 9.53% 9.41% 7.94% 7.76% -
ROE 13.77% 13.25% 12.70% 11.64% 11.61% 9.39% 8.92% -
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
RPS 746.36 660.96 657.54 635.01 629.16 619.32 591.41 16.83%
EPS 63.63 59.49 57.17 50.64 50.37 40.10 37.47 42.47%
DPS 32.00 42.00 39.00 36.54 30.28 24.00 22.85 25.24%
NAPS 4.62 4.49 4.50 4.35 4.34 4.27 4.20 6.57%
Adjusted Per Share Value based on latest NOSH - 940,634
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
RPS 346.15 306.67 304.97 294.68 290.00 282.66 266.01 19.24%
EPS 29.51 27.60 26.52 23.50 23.22 18.30 16.85 45.44%
DPS 14.85 19.46 18.03 16.96 13.96 10.95 10.28 27.87%
NAPS 2.1427 2.0833 2.0871 2.0186 2.0004 1.9488 1.8891 8.78%
Price Multiplier on Financial Quarter End Date
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Date 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 -
Price 5.51 5.22 4.79 4.38 3.52 3.13 3.08 -
P/RPS 0.74 0.79 0.73 0.69 0.56 0.51 0.52 26.59%
P/EPS 8.66 8.77 8.38 8.65 6.99 7.80 8.22 3.54%
EY 11.55 11.40 11.94 11.56 14.31 12.81 12.16 -3.38%
DY 5.81 8.05 8.14 8.34 8.60 7.67 7.42 -15.08%
P/NAPS 1.19 1.16 1.06 1.01 0.81 0.73 0.73 38.63%
Price Multiplier on Announcement Date
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Date 18/08/11 27/05/11 25/02/11 29/11/10 23/08/10 31/05/10 25/02/10 -
Price 4.90 5.10 4.81 4.68 3.88 3.15 3.03 -
P/RPS 0.66 0.77 0.73 0.74 0.62 0.51 0.51 18.81%
P/EPS 7.70 8.57 8.41 9.24 7.70 7.85 8.09 -3.24%
EY 12.99 11.66 11.89 10.82 12.98 12.73 12.37 3.32%
DY 6.53 8.24 8.11 7.81 7.80 7.62 7.54 -9.16%
P/NAPS 1.06 1.14 1.07 1.08 0.89 0.74 0.72 29.50%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment